Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
21-Jan-2026 | 868 | 884 | 868 | 876.25 | 58,873 | 79,11,69,841.8 | 4,33,596 |
22-Jan-2026 | 876.25 | 888 | 875.8 | 885.3 | 40,023 | 41,54,91,633.5 | 2,35,763 |
23-Jan-2026 | 886.5 | 897.15 | 880 | 882 | 34,182 | 40,81,62,350.6 | 1,95,549 |
27-Jan-2026 | 890 | 894.95 | 879.9 | 893.35 | 34,511 | 43,63,44,909.25 | 2,58,671 |
28-Jan-2026 | 892.5 | 899.2 | 886.45 | 896.9 | 24,085 | 27,94,61,624.95 | 1,69,184 |
29-Jan-2026 | 893 | 894 | 881.15 | 890.7 | 25,326 | 35,77,03,557.05 | 1,97,821 |
30-Jan-2026 | 884.25 | 896.15 | 882.45 | 885.3 | 33,881 | 58,69,84,039.65 | 4,25,290 |
01-Feb-2026 | 881 | 897 | 875.95 | 878.1 | 13,357 | 15,31,53,118.75 | 56,003 |
02-Feb-2026 | 876.3 | 882 | 863.65 | 879.65 | 32,649 | 35,42,17,536.65 | 1,94,206 |
03-Feb-2026 | 901 | 916.85 | 895.25 | 902.9 | 34,998 | 94,89,59,516.2 | 5,35,315 |
04-Feb-2026 | 905.2 | 912.5 | 898.65 | 905.25 | 30,316 | 44,89,30,335.6 | 2,01,530 |
05-Feb-2026 | 909.25 | 910 | 896.6 | 905 | 29,048 | 37,92,56,375.1 | 1,90,119 |
06-Feb-2026 | 905 | 905 | 884 | 888.15 | 34,496 | 43,78,43,399.5 | 2,55,460 |
09-Feb-2026 | 897.45 | 933.35 | 884 | 923.45 | 74,341 | 1,90,90,29,544.7 | 4,73,258 |
10-Feb-2026 | 920 | 920 | 884.3 | 887.3 | 67,864 | 2,03,13,29,073.35 | 7,56,641 |
11-Feb-2026 | 888.9 | 899.8 | 882 | 898.3 | 35,435 | 75,25,10,201.8 | 2,93,520 |
12-Feb-2026 | 900.3 | 926.2 | 896.05 | 920.95 | 46,818 | 1,48,14,58,698.8 | 4,57,687 |
13-Feb-2026 | 920.95 | 923.4 | 897.3 | 904.7 | 19,709 | 43,00,73,486.75 | 1,86,452 |
16-Feb-2026 | 905 | 916.45 | 905 | 910.45 | 14,408 | 39,91,30,952.15 | 1,59,192 |
17-Feb-2026 | 910 | 914.15 | 903.55 | 906.65 | 15,069 | 21,27,59,596.05 | 81,702 |
18-Feb-2026 | 910 | 912.9 | 900.2 | 910.05 | 16,863 | 26,39,66,916.3 | 1,38,437 |
19-Feb-2026 | 919.75 | 919.75 | 900.3 | 902.4 | 25,147 | 67,04,84,157.55 | 1,85,181 |
Zydus Life stated that it has unveiled the biosimilar under the brand Tishtha™. It can be used for treatment of multiple cancers.
It further added that the company will raise funds via qualified institutional placement (QIP) to part-fund the acquisition.
NUFYMCO is a vascular endothelial growth factor inhibitor designed to treat serious ophthalmic conditions, particularly those affecting retinal health.
Here are some of the stocks that may see significant price movement today: HCL Technologies, Zydus Lifesciences, Intellect Design Arena, etc.
The company plans to manufacture these tablets at its formulation manufacturing facility situated in the SEZ in Ahmedabad.
Ravishanker Kovi, the founder and executive chairman of RK Pharma, commented that Zydus Life has a powerful commercial footprint.
The approved product is a biosimilar of the US reference listed drug Calan SR extended-release tablets in the same vials.
The product is a generic version of Lynparza Tablets developed by AstraZeneca.
Here are some of the stocks that may see significant price movement: Bharti Airtel, Cipla, Gland Pharma, etc.
Here are some of the stocks that may see significant price movement today: Tata Motors, TVS Motors, Zydus Lifesciences, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
